Ganymede Bio, the Cloud Provider Purpose-Built for the Life Sciences and Manufacturing Industries, Raises $12.75 Million in Series A Funding

PALO ALTO, Calif.--(BUSINESS WIRE)--Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, today announced a $12.75 million Series A funding round, led by Caffeinated Capital. This follows a $2.9 million seed round completed earlier this year, bringing the total to over $15.6 million. Founded in...

Click to view original post